Brain Volume Differences Found in Patients With HIV Infection
In HIV-infected adults, lower CD4+ T-cell counts were associated with smaller hippocampal and thalamic brain volumes regardless of treatment status.
In HIV-infected adults, lower CD4+ T-cell counts were associated with smaller hippocampal and thalamic brain volumes regardless of treatment status.
A new point-of-care lateral flow assay featured the same sensitivity as mycobacterial culture in detecting tuberculosis meningitis in adults with HIV.
People with HIV, particularly patients in sub-Saharan Africa and Latin America, have a high burden of HIV-associated neurocognitive disorder.
Excess mortality occurred as the result of a number of causes, including overdose, injuries, and both infectious and noncommunicable diseases.
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
Dolutegravir (DTG) discontinuation due to neuropsychologic side effects (NPS) may be associated with pre-existing psychiatric conditions of depression and anxiety.
Telmisartan did not affect biomarkers of central nervous system inflammation or injury when used as an adjunct to ART for acute HIV infection.
The prevalence of neural tube defects (NTDs) in births to mothers with HIV from 2013 to 2017 was estimated to be 7.0 per 10,000 live births.
The prevalence of neural tube defects (NTDs) is 7.0 per 10,000 live births in HIV-exposed pregnancies, which is similar to the prevalence in the general population.
Although the prevalence of distal sensory peripheral neuropathy decreased following initiation of cART in people living with in resource-limiting settings, better strategies are needed.